{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:45:04Z","timestamp":1783975504336,"version":"3.55.0"},"reference-count":22,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,4,5]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare peroxisomal disorder causing pristanic acid accumulation. Only 16 cases have been described so far. A female in her seventh decade presented with episodes of dysphasia, headache and sensory disturbance inconsistent with migraine, epilepsy or transient ischaemic attack. An MRI demonstrated unusual changes in the pons, red nuclei, thalami and white matter. Mitochondrial disease was suspected but detailed testing was negative. After eight\u2009years of symptoms, she developed a febrile encephalopathy with hemispheric dysfunction, focal convulsive seizures and coma. Her condition stabilised after one\u2009month. Lacosamide was continued for seizure prevention. The diagnosis remained elusive until whole genome sequencing revealed AMACR deficiency. Pristanic acid levels were highly elevated and dietary modification was recommended. Genetic peroxisomal disorders can present in older age; our patient is the oldest in the AMACR deficiency literature. Novel features in our case include central apnoea, dystonia and rapid eye movement behaviour disorder.<\/jats:p>","DOI":"10.1136\/bcr-2021-247964","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T11:20:25Z","timestamp":1650021625000},"page":"e247964","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Late onset AMACR deficiency with metabolic stroke-like episodes and seizures"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8258-9634","authenticated-orcid":false,"given":"Matthew J","family":"Tanti","sequence":"first","affiliation":[{"name":"Department of Neurology, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J","family":"Maguire","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bamford","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"2025082710562008000_15.4.e247964.1","doi-asserted-by":"crossref","unstructured":"Aubourg P , Wanders R , disorders P . Peroxisomal disorders. 1 edn. Elsevier B.V, 2013.","DOI":"10.1016\/B978-0-12-383834-6.00110-5"},{"key":"2025082710562008000_15.4.e247964.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(01)00011-X"},{"key":"2025082710562008000_15.4.e247964.3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204639200"},{"key":"2025082710562008000_15.4.e247964.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.08.005"},{"key":"2025082710562008000_15.4.e247964.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.03.011"},{"key":"2025082710562008000_15.4.e247964.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.129478"},{"key":"2025082710562008000_15.4.e247964.7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-1"},{"key":"2025082710562008000_15.4.e247964.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.161059"},{"key":"2025082710562008000_15.4.e247964.9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/01.WNL.0000132841.81250.B7","article-title":"Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency","volume":"63","author":"Clarke","year":"2004","journal-title":"Neurology"},{"key":"2025082710562008000_15.4.e247964.10","doi-asserted-by":"publisher","DOI":"10.1016\/0955-3886(93)90049-Z"},{"key":"2025082710562008000_15.4.e247964.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.3.396"},{"key":"2025082710562008000_15.4.e247964.12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ICB.0b013e3181f047dd","article-title":"Fundus findings in a patient with \u03b1-methlyacyl-coa racemase deficiency","volume":"5","author":"Stewart","year":"2011","journal-title":"Retin Cases Brief Rep"},{"key":"2025082710562008000_15.4.e247964.13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10545-010-9183-6","article-title":"An adult onset case of alpha-methyl-acyl-CoA racemase deficiency","volume":"33 Suppl 3","author":"Smith","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"2025082710562008000_15.4.e247964.14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/164_2016_2","article-title":"Toxicity of antiepileptic drugs to mitochondria","volume":"240","author":"Finsterer","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"2025082710562008000_15.4.e247964.15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ene.14588","article-title":"Episodic hyperCKaemia may be a feature of \u03b1-methylacyl-coenzyme a racemase deficiency","volume":"28","author":"Krett","year":"2021","journal-title":"Eur J Neurol"},{"key":"2025082710562008000_15.4.e247964.16","doi-asserted-by":"publisher","DOI":"10.1038\/72861"},{"key":"2025082710562008000_15.4.e247964.17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.0b013e3181f612a5","article-title":"Relapsing rhabdomyolysis due to peroxisomal alpha-methylacyl-CoA racemase deficiency","volume":"75","author":"Kapina","year":"2010","journal-title":"Neurology"},{"key":"2025082710562008000_15.4.e247964.18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821a4484"},{"key":"2025082710562008000_15.4.e247964.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00877.x"},{"key":"2025082710562008000_15.4.e247964.20","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50017"},{"key":"2025082710562008000_15.4.e247964.21","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/ajmg.a.35611","article-title":"Incidental finding of alpha-methylacyl-CoA racemase deficiency in a patient with oculocutaneous albinism type 4","volume":"158A","author":"Verhagen","year":"2012","journal-title":"Am J Med Genet A"},{"key":"2025082710562008000_15.4.e247964.22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.24953\/turkjped.2019.02.023","article-title":"Alpha methyl acyl CoA racemase deficiency: diagnosis with isolated elevated liver enzymes","volume":"61","author":"G\u00fcnd\u00fcz","year":"2019","journal-title":"Turk J Pediatr"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-247964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:56:28Z","timestamp":1756317388000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-247964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,15]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bcr-2021-247964"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-247964","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}